Medistep Healthcare (NSE:MEDISTEP) Notes Receivable: ₹0.0 Mil (As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:MEDISTEP Medistep Healthcare Ltd NSE:MEDISTEP
19 GF Score
Price ₹18.50
! 2 Warning Signs
View Full Analysis

What is Medistep Healthcare Notes Receivable?

Medistep Healthcare NSE:MEDISTEP -2.63% 19 Notes Receivable is ₹0.0 Mil as of Sep. 2025. GuruFocus rates NSE:MEDISTEP with a GF Score™ of 19/100. The stock has 2 warning signs investors should review.

Medistep Healthcare's Notes Receivable for the quarter that ended in Sep. 2025 was ₹0.0 Mil.

Medistep Healthcare Notes Receivable Related Terms

Medistep Healthcare Notes Receivable Historical Data

* Premium members only.

The historical data trend for Medistep Healthcare's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medistep Healthcare Notes Receivable Chart

Medistep Healthcare Annual Data
Trend Mar22 Mar23 Mar24 Mar25
Notes Receivable
0.00 0.00 0.00 0.00

Medistep Healthcare Semi-Annual Data
Mar22 Mar23 Mar24 Sep24 Mar25 Sep25
Notes Receivable Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
NSE:MEDISTEP
19GF Score
Medistep Healthcare Ltd NSE:MEDISTEP
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medistep Healthcare Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of ₹0.0 Mil mean?
Medistep Healthcare (NSE:MEDISTEP) has a Notes Receivable of ₹0.0 Mil as of Sep. 2025. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Medistep Healthcare and its competitors.
Is Medistep Healthcare's Notes Receivable too high?
Medistep Healthcare's current Notes Receivable is ₹0.0 Mil. Overall, Medistep Healthcare has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Medistep Healthcare's Notes Receivable compare to MCK and CAH?
Medistep Healthcare's Notes Receivable of ₹0.0 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Medical Distribution company?
A good Notes Receivable depends on the Medical Distribution industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Medistep Healthcare and its competitors. Medistep Healthcare's current Notes Receivable is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medistep Healthcare stock overvalued right now?
Medistep Healthcare (NSE:MEDISTEP) has a current Notes Receivable of ₹0.0 Mil. The current Notes Receivable is ₹0.0 Mil. Medistep Healthcare's overall GF Score™ is 19/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Medistep Healthcare (NSE:MEDISTEP), the current Notes Receivable is ₹0.0 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medistep Healthcare Business Description

Address National Highway 8, 05, S. No-245/B, Plot-19, T.P.S. 56, Free Way Trade Center, Near A-One Hotel, Narol Gam, Narol, Daskroi, Ahmadabad, GJ, IND, 382405
Medistep Healthcare Ltd operates in the pharmaceutical and healthcare product sectors. Its business includes manufacturing intimate care and hygiene products such as sanitary pads, as well as nutraceutical products like energy powders. The company also trades a variety of pharmaceutical, surgical, and medical equipment products. Medistep Healthcare's operations focus mainly on the western region of India, particularly in Gujarat. Its Core business activity is divided into the following categories: a) Trading of Pharmaceutical & Surgical products, b) Trading & Manufacturing of Nutraceuticals and Intimate care & hygiene products. The company generates the majority of its revenue from Trading and distribution.
19GF Score

Get the complete analysis for NSE:MEDISTEP

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹18.50
Price